Biochanin A Regulates Microglia Polarization After SCI by Promoting Autophagy and Blocking the TLR4/NF-κB Pathway

Author:

Li Xigong1,Fu Jing2,Gao Zhongyang1,Shi Haifei1,Pan Wenming3,Lou Xianfeng1

Affiliation:

1. Department of Orthopaedics, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China

2. Department of Stomatology, Hangzhou XixiHospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310023, China

3. Department of Orthopedic, Spine Surgery, The Affiliated Hospital of Xuzhou Medical School, The Second People’s Hospital of Changshu, Changshu, Jiangsu, 221006, China

Abstract

Spinal cord injury (SCI) is frequently accompanied by sensorimotor deficits that persist for years in the absence of effective treatments. Biochanin A (BCA), a natural isoflavone, belongs to phytoestrogen. BCA can perform multiple functions, but its role of SCI is unclear. The purpose of this study was to explore the impact and mechanism of BCA on microglia by simulating SCI with lipopolysaccharide (LPS) in vitro. The results showed that BCA inhibited microglial apoptosis and promoted SCI repair by inducing M2 microglia polarization and secretion of anti-inflammatory factors. Notably, the efficacy of the above-mentioned effects of BCA was correlated with autophagic flux. We further explored the underlying molecular mechanisms and confirmed the critical importance of toll-like receptor 4 (TLR4) in counteracting the effect of BCA on LPS-BV-2 cells. The TLR4/NF-κB pathway was shown to promote M1 microglial polarization, inflammation and cellular apoptosis. In conclusion, BCA blocks the TLR4/NF-κB pathway to inhibit M1 microglial polarization and apoptosis after SCI. This study is expected to provide the scientific basis for the SCI.

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3